688319.SH
Chengdu Olymvax Biopharmaceuticals, Inc.
SSE · Healthcare · Biotechnology · CN
CNY 25.91
+2.70%Leverage
- Debt / equity
- 0.35x
- Net debt / equity
- 0.15x
- Debt / assets
- 0.16x
- Debt / EBITDA
- 4.73x
- Net debt / EBITDA
- 1.97x
Liquidity & coverage
- Current ratio
- 1.36x
- Quick ratio
- 1.26x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- CNY 261.7M
Cash & dividend
- FCF / debt
- 0.00x
- Cash flow / debt
- 0.31x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026